Next Article in Journal
Hsp90 Inhibitors and the Reduction of Anti-Cancer Drug Resistance by Non-Genetic and Genetic Mechanisms
Next Article in Special Issue
Why and How the Old Neuroleptic Thioridazine Cures the XDR-TB Patient
Previous Article in Journal
A Perspective on the Comparative Antileukemic Activity of 5-Aza-2′-deoxycytidine (Decitabine) and 5-Azacytidine (Vidaza)
Previous Article in Special Issue
Chemotherapeutic Interventions Against Tuberculosis
Due to scheduled maintaince work on one of the switches in our server center, our websites www.mdpi.com and susy.mdpi.com may experience short service dirsuptions of up to 5 minutes on 30 January 2015 00:00 PM EST time.
Pharmaceuticals 2012, 5(8), 882-889; doi:10.3390/ph5080882

Notes on Article Versions

NoteDate
article html file updated24 January 2013 00:25 CET
article html file updated27 January 2013 03:13 CET
article html file updated29 January 2013 06:04 CET
article html file updated6 February 2013 09:49 CET
article html file updated7 February 2013 05:32 CET
article html file updated7 February 2013 14:29 CET
article xml file uploaded6 August 2013 16:06 CEST
article html file updated6 August 2013 16:07 CEST
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert